Savvy Updates, 9/6/22: Senseonics CFO Leaves, Beta Bionics Trial Data & RIF, Chip-free, Wireless Electronic Skin, Insulin Pill, Cognitive Benefits from Hybrid Closed Loop Systems, Sugar & Microbiome, T1D & Hypothyroidism
Senseonics Announces CFO Transition was published by Senseonics Holdings, Inc., 1 September 2022. Senseonics, a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems...
Savvy Updates 8/15/22: Comments on CGM Alarms to FDA DEADLINE 8/15/2022, Inflation Reduction Act Becomes Law, Glucagon Emergency Kit Discontinued, Sensor Jewelry, Dr. Francine Kaufman on Senseonics, Omnipod 5 vs. Tandem Diabetes, Monkey Pox & T1D
Final Day: Make Your Voice Heard AGAIN to the FDA re CGM! Here’s another chance to tell them, in a few short sentences, what you want, regarding CGM (continuous glucose monitoring) alarms! The FDA has mandated that CGM LOW BG alarms MAY NOT be turned off or...
Savvy Updates, 7/25/22: GSK-126 Restores Beta Cells, SpaceX Grows Stem Cells, Trigger Finger/Carpal Tunnel Gene Variant, UnitedHealthcare $0 Insulin CoPay Only Will Affect Few, POGO BG Meter UPDATE
Experimental drug may help restore insulin-producing cells was written by Clarissa Brincat for MedicalNewsToday.com, 22 July 2022. In a recent study, the human epigenetics team at Monash University in Melbourne, Australia, found that the investigational drug GSK-126...
Savvy Updates, 7/18/22: Power of YOUR VOICES to the US FDA, Timely Access to Care Act, About Chocolate
Diabetes Patients Flood FDA with Comments on Cybersecurity for Medical Devices, as reported by Mariam Baksh for NextGov.com, 8 July 2022. The Food and Drug Administration received more than a thousand comments—mainly from diabetes patients and their family...
Savvy Updates, 7/11/22: Vertex Resumes Testing, US Senate Dems Move to Lower Drug Prices, Potatoes Better with Vinegar, Sugar Cravings Reduce by New Gum
Vertex, continuing its rebound, cleared to resume testing of diabetes cell therapy was written by Ben Fidler for BioPharmaDive.com, 6 July 2022. The Food and Drug Administration has cleared Vertex Pharmaceuticals to resume a study evaluating an...
More Diabetes Blogs